ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 249,83
0,37%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Accelerate Diagnostics Inc (AXDX)

  7. Accelerate Diagnostics Inc (AXDX) Actualités

AXDX

Accelerate Diagnostics (AXDX)

Accelerate Diagnostics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AXDX
DateHeureSourceTitreSymboleSociété
05/06/202423h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXDXAccelerate Diagnostics Inc
03/06/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXDXAccelerate Diagnostics Inc
24/05/202401h17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
10/05/202423h24Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
08/05/202422h42PR Newswire (US)Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
02/05/202415h30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
28/03/202421h05PR Newswire (US)Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
07/03/202415h30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.NASDAQ:AXDXAccelerate Diagnostics Inc
05/03/202421h59Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXDXAccelerate Diagnostics Inc
23/01/202403h59Edgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:AXDXAccelerate Diagnostics Inc
22/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AXDXAccelerate Diagnostics Inc
19/01/202415h20PR Newswire (US)Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private PlacementNASDAQ:AXDXAccelerate Diagnostics Inc
18/01/202413h19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
16/01/202413h45PR Newswire (US)Accelerate Diagnostics Announces Launch of Proposed Public OfferingNASDAQ:AXDXAccelerate Diagnostics Inc
08/01/202402h00PR Newswire (US)Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
13/12/202323h30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AXDXAccelerate Diagnostics Inc
27/11/202315h15PR Newswire (US)Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®NASDAQ:AXDXAccelerate Diagnostics Inc
09/11/202323h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXDXAccelerate Diagnostics Inc
09/11/202322h05PR Newswire (US)Accelerate Diagnostics Reports Third Quarter 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
30/10/202314h30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
10/08/202322h05PR Newswire (US)Accelerate Diagnostics Reports Second Quarter 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
27/07/202315h30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
11/07/202302h04Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
10/07/202315h00PR Newswire (US)Accelerate Diagnostics Announces 1-for-10 Reverse Stock SplitNASDAQ:AXDXAccelerate Diagnostics Inc
30/06/202300h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXDXAccelerate Diagnostics Inc
21/06/202312h05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AXDXAccelerate Diagnostics Inc
20/06/202323h11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXDXAccelerate Diagnostics Inc
13/06/202316h57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXDXAccelerate Diagnostics Inc
13/06/202315h00PR Newswire (US)Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform WaveNASDAQ:AXDXAccelerate Diagnostics Inc
02/06/202300h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AXDXAccelerate Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:AXDX

Dernières Valeurs Consultées

NASDAQ
AMZN
Amazon.com
COIN
BTCUSD
Bitcoin
EU
PX1
CAC 40
NYSE
MRK
Merck
EU
AI
Air Liquide
NASDAQ
GOOGL
Alphabet
EU
BNP
BNP Paribas
EU
ML
Michelin
EU
ACA
Credit Agricole
EU
RI
Pernod Ricard
EU
GLE
Societe Generale
EU
BEL20
Bel 20
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés